Volpi Group’s Auburn expansion tied to growth and its role in the COVID-19 fight

Global optoelectronics innovator partnering with global leaders in the COVID fight and expanding its facility, sales team, and digital presence

Volpi Group, a global life sciences and diagnostics optoelectronics leader with headquarters in Zurich and Auburn, announced several new growth initiatives this week.

Fight against COVID-19

Volpi’s optoelectronic modules, fiber assemblies, and other critical components are being shipped at record levels to enable its customers, including Ortho Clinical Diagnostics, Qiagen, Luminex, Siemens, and others help meet urgent research, physician and patient needs.

Volpi products are a critical part of instruments being utilized in COVID-19 testing, antibody testing, blood gas analysis, as well as the assessment of overall health and critical underlying conditions.

$2 million Auburn facility expansion completed

To respond to the COVD-19 challenge and to further fuel Volpi's already rapid growth, it recently completed a $2 million construction project, renovating 15,000 square feet at our Auburn campus - adding cleanrooms, a new HVAC system to provide optimal temperature, humidity, and positive pressure control, re-routing electrical, cabling, plumbing, and process gas throughout the facility, a more efficient layout/flow and upgraded production and IT equipment.

"We're very excited to have completed this very important project,"  says Max Kunz, CEO of Sales and Strategy. "This will greatly increase our production capacity and optical module assembly and test capabilities for our critical IVD and Life Sciences customers globally."

Sales team grows

Volpi is pleased to welcome Dr. Lidza Kalifa as a Business Development Manager in our US headquarters in Auburn, NY. Lidza joins Volpi following roles at both IDEX Health and Science and Rochester Precision Optics. Lidza earned her B.S. in Molecular Genetics, M.S. in Biology, and a Ph.D. in Biology at the University of Rochester where her studies focused on mitochondrial DNA replication and repair, followed by postdoctoral work in epigenetics and carcinogenesis, and subsequently toxicology.

Expanded digital presence

Volpi also announced it has launched its new website to better communicate how it helps Life Sciences and In Vitro Diagnostic customers improve patient’s lives by improving the instruments designed to diagnose and treat them through optoelectronics innovation.

 ###

About Volpi

Volpi helps healthcare professionals make more informed treatment decisions by delivering innovative optoelectronic solutions that enhance the performance of the diagnostic instruments used to research and diagnose disease. We improve patient’s lives through light-created insights. Light. Insight. Life.